2022 HMTRC Workshop
The March 2022 Hyperpolarized Carbon-13 MRI Technology Development Workshop includes lectures, hands-on training and discussions on dissolution DNP methodology, polarizer instrumentation, MR Sequence and Acquisitions, Pre-clinical HP Chemistry Preps, Human HP Investigational Dose Formulation & Production, Clinical Translation Methods, Clinical Trial Support, and Analysis & Display Software.
View Agenda
Photo credits 2022 HMTRC Workshop: UCSF Campus Life Services/Marco Sanchez
2022 Workshop Video Presentations
See below for the Workshop Recording links.
Please note that presentations with an "*" indicate that the presentation is NOT available for viewing
Day 1:
Center TR&D Presentations
8:00 AM - 9:00 AM
• Introductions: HMTRC Director, Dr. Dan Vigneron PhD & Chair of Radiology & Biomedical Imaging, Dr. Christopher Hess MD, PhD
• Center Updates on Hyperpolarized C-13 MRI Technology Development: HMTRC Director, Dr. Dan Vigneron PhD
• Technology Development for Polarizer and Detector Instrumentation: Dr. Jeremy Gordon PhD & Andrew Riselli PharmD, UCSF
• Development of Novel Hyperpolarized MR Molecular Imaging Probes Tested in Realistic Preclinical Models and Correlative Science Studies: Drs. John Kurhanewicz PhD & Renuka Sriram PhD, UCSF
• Acquisition and Analysis Methods for Hyperpolarized MR Data: Drs. Peder Larson PhD & Duan Xu PhD, UCSF
Day 1:
Plenary Presentations
9:00 AM - 12:30 PM
• Dr. Jane Wang MD, HP Medical Director, UCSF*
• Dr. Jan H. Ardenkjaer-Larsen PhD, Danmarks Tekniske Universitet: SpinAligner
• Dr. Rahul Aggarwal MD, UC San Francisco: Emerging Clinical Applications of Hyperpolarized 13C MRI in Prostate Cancer
• Dr. Charlie Khemtong PhD, University of Florida: Evaluation of Cellular Redox in Perfused Hearts with HP 13C MR
• Dr. Michael Ohliger MD, PhD, UC San Francisco: Hyperpolarized 13C in the Liver
• Dr. Aaron Grant PhD, Harvard University: Perfusion Imaging with a Diffusible Tracer
• Dr. Craig Malloy MD, UT Southwestern Medical Center: Progress in Detection of PDH and the TCA cycle by 13C NMR
• Dr. Matt Merritt PhD, University of Florida: Detecting Real-Time Hepatic Ketogenesis with HP [2-13C]Pyruvate
• Dr. Rob Flavell MD, PhD, UC San Francisco: Molecular Imaging of Tumor pH with Hyperpolarized 13C MRI
Day 1:
Keynote Presentations
5:00 PM - 6:00 PM
• Keynote Lecture by Dr. Christoffer Laustsen PhD, Aarhus University, Denmark: New Nuero Applications in Aarhus - Future Considerations
• Keynote Lecture by Dr. Susan Chang MD, UC San Francisco: Metabolic Imaging in Glioma
Day 2:
Industry Presentations
8:15 AM - 9:30 AM
- Drs. Arnaud Comment PhD, Rui Chen PhD, Albert Chen PhD, GE Healthcare Scientists*
- Chris Suszczynski, Isotec Stable Isotopes Division, MilliporeSigma*
- Dr. Titus Lanz PhD, RAPID Biomedical GmbH: 13C Four-Rung Birdcage Coil for Abdomen – First Results
Day 2: Plenary Presentations
2:00 PM - 5:00 PM
- Dr. Cornelius von Morze PhD, Washington University in St. Louis: Recent Progress on HP 13C/15N MRI at Wash U
- Dr. James Kempf PhD, Bruker Scientist: 13C Imaging & Dissolution DNP with Bruker
- Dr. Robert Bok MD, PhD, UC San Francisco: Clinical Studies with HP C-13 MRI
- Dr. Kazu Yamamoto PhD, National Cancer Institute*
- Dr. Mary McLean PhD & Ali Khan, University of Cambridge: Clinical Deuterium and Hyperpolarized 13C MR Imaging at Cambridge
- Dr. James Bankson PhD, MD Anderson Medical Center*
- Max Bullock & Dr. Adam Retter MD, University College London: UCL Hyperpolariser Update
- Drs. Philipp Biegger PhD & Andreas Korzowski PhD, German Research Cancer Center: Hyperpolarized 13C MRI @ DKFZ
- Dr. Yi-Fen Yen PhD, Harvard University: Status of Hyperpolarized Metabolic Imaging at MGH
- Drs. Gigin Lin MD PhD & Jay Lai MD, Chang Gung Hospital, Taiwan: Dynamic Nuclear Polarization (DNP) Asian Perspective
